EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome

Monika E Jach iD, Ewa Sajnaga iD, Marharyta Bumbul iD, Anna Serefko iD, Kinga K Borowicz iD, Hieronim Golczyk iD, Marek Kieliszek iD, Adrian Wiater iD

Molecules · 2025

DOI: 10.3390/molecules30204130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Monika E Jach und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Medical Faculty, The John Paul II Catholic University of Lublin, Konstantynów Street 1I, 20-708 Lublin, Poland. Hauptthemen laut MEDLINE: Probiotics, Post-Acute COVID-19 Syndrome, SARS-CoV-2, Gastrointestinal Microbiome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-COVID-19 syndrome, also known as long-COVID, is characterized by a wide spectrum of persistent symptoms involving multiple body organs and systems, including fatigue, gastrointestinal disorders, and neurocognitive dysfunction. Emerging evidence suggests that gut microbiota dysbiosis and disruption of the gut–brain axis play a central role in the pathophysiology of this condition. Probiotics and their metabolites (postbiotics) have gained increasing attention as potential therapeutic agents given their immunomodulatory, anti-inflammatory, and antiviral properties. In this review, we discuss the current understanding of the antiviral mechanisms of probiotics, including reinforcement of intestinal epithelial barrier function, direct virus inhibition, receptor competition, and immune system modulation. Special emphasis is placed on short-chain fatty acids (SCFAs), lactic acid, hydrogen peroxide, and bacteriocins as key factors that contribute to these effects. SCFAs appear to be essential postbiotic compounds during post-COVID recovery. We also highlight recent clinical trials involving specific probiotic species, such as Lactiplantibacillus plantarum, Lacticaseibacillus rhamnosus, and Bifidobacterium longum, and their potential role in alleviating long-term COVID symptoms. Although the current results are promising, further research is needed to clarify the most effective strains, dosages, and mechanisms of action in post-COVID therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsPost-Acute COVID-19 SyndromeSARS-CoV-2Gastrointestinal MicrobiomeHumansFatty Acids, VolatileVirus ReplicationBrain-Gut AxisNeuropsychological Tests

Stichwörter der Autor:innen

SARS-CoV-2SCFAsantiviral mechanismsgut–brain axisgut–lung axislong COVIDmicrobiotapost-COVIDpost-acute COVID-19 syndromepostbioticsprobiotics

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Molecular Biology, Medical Faculty, The John Paul II Catholic University of Lublin, Konstantynów Street 1I, 20-708 Lublin, Poland.
  • Department of Biomedicine and Environmental Research, Medical Faculty, The John Paul II Catholic University of Lublin, Konstantynów Street 1J, 20-708 Lublin, Poland.
  • Medical Faculty, The John Paul II Catholic University of Lublin, Konstantynów Street 1I, 20-708 Lublin, Poland.
  • Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Lublin, Chodźki Street 1, 20-093 Lublin, Poland.
  • Independent Unit of Experimental Neuropathophysiology, Department of Toxicology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.
  • Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences-SGGW, Nowoursynowska Street 159C, 02-776 Warsaw, Poland.

ORCID-Profile: Monika E Jach, Ewa Sajnaga, Marharyta Bumbul, Anna Serefko, Kinga K Borowicz, Hieronim Golczyk, Marek Kieliszek, Adrian Wiater

Zitieren

APA

Jach, M. E., Sajnaga, E., Bumbul, M., Serefko, A., Borowicz, K. K., Golczyk, H., Kieliszek, M., & Wiater, A. (2025). The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome. Molecules. https://doi.org/10.3390/molecules30204130

Vancouver

Jach ME, Sajnaga E, Bumbul M, Serefko A, Borowicz KK, Golczyk H, et al. The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome. Molecules. 2025. doi:10.3390/molecules30204130

BibTeX
@article{Jach2025,
  author = {Jach, Monika E and Sajnaga, Ewa and Bumbul, Marharyta and Serefko, Anna and Borowicz, Kinga K and Golczyk, Hieronim and Kieliszek, Marek and Wiater, Adrian},
  title = {The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30204130}
}
Kostenlos starten →